A bone-protective role for IL-17 receptor signaling in ovariectomy-induced bone loss
Open accessThe DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Abstract
Post-menopausal osteoporosis is considered to be an inflammatory process, in which numerous pro-inflammatory and T-cell-derived cytokines play a bone-destructive role. IL-17A is the signature cytokine of the pro-inflammatory Th17 population and plays dichotomous roles in diseases that affect bone turnover. Although IL-17A promotes bone loss in rheumatoid arthritis, it is protective against pathogen-induced bone destruction in a periodontal disease model. We used a model of ovariectomy-induced osteoporosis (OVX) in IL-17 receptor (IL-17RA)(-/-) mice to evaluate the role of the IL-17A in bone loss caused by estrogen deficiency. Unexpectedly, IL-17RA(-/-) mice were consistently and markedly more susceptible to OVX-induced bone loss than controls. There were no changes in prototypical Th1, Th2 or Th17 cytokines in serum that could account for increased bone loss. However, IL-17RA(-/-) mice exhibited constitutively elevated leptin, which further increased following OVX. Consistently, IL-17A and IL-17F treatment of 3T3-L1 pre-adipocytes inhibited adipogenesis, leading to reduced production of leptin. In addition to its role in regulating metabolism and satiety, leptin can regulate bone turnover. Accordingly, these data show that IL-17A negatively regulates adipogenesis and subsequent leptin expression, which correlates with increased bone destruction during OVX.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Mice deficient in IL-17 and fed regular chow gain increased fat mass with age, corresponding to a role for IL-17 in regulating glucose homeostasis and inhibiting adipogenesis”
From The IL-17 Family of Cytokines in Health and Disease (2019) · cites this paper as Goswami et al., 2009
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
IL-23 drives a pathogenic T cell population that induces autoimmune inflammation
Langrish, C. L., Chen, Y., Blumenschein, W. M., Mattson, J., Basham, B., Sedgwick, J. D., McClanahan, T., Kastelein, R. A., & Cua, D. J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041257 · Cited by 4,099 · cited 1×
“IL-17A and the related cytokine IL-17F are produced by a newly-discovered subset of T helper lymphocytes, termed Th17 cells [2].”
Manolagas, S. C. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.2.0395 · Cited by 2,568 · cited 2×
“Estrogen deficiency also increases the RANKL:OPG ratio through increases in pro-inflammatory effectors, including IL-1b, IL-6, IL-11, TNF-a, M-CSF and PGE2 [33–35].”
Sex Steroids and the Construction and Conservation of the Adult Skeleton
Riggs, B. L., Khosla, S., & Melton, L. J. (2002) · Endocrine Reviews · doi:10.1210/edrv.23.3.0465 · Cited by 1,846 · cited 2×
“Estrogen deficiency also increases the RANKL:OPG ratio through increases in pro-inflammatory effectors, including IL-1b, IL-6, IL-11, TNF-a, M-CSF and PGE2 [33–35].”
IL-17 family cytokines and the expanding diversity of effector T cell lineages
Weaver, C. T., Hatton, R. D., Mangan, P. R., & Harrington, L. E. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141557 · Cited by 1,842 · cited 2×
“TGFβ controls Th17 differentiation, together with IL-6 and IL-1 (reviewed in [3]).”
Sato, K., Suematsu, A., Okamoto, K., Yamaguchi, A., Morishita, Y., Kadono, Y., Tanaka, S., Kodama, T., Akira, S., Iwakura, Y., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061775 · Cited by 1,554 · cited 1×
“In addition, Th17 cells express high levels of RANKL, providing a direct mechanism by which they may drive mediate bone destruction [5].”
T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines
Fossiez, F., Djossou, O., Chomarat, P., Flores-Romo, L., Ait-Yahia, S., Maat, C., Pin, J. J., Garrone, P., Garcia, E., Saeland, S., et al. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.183.6.2593 · Cited by 1,526 · cited 1×
“IL-17A induces production of TNF-α and IL-1β in macrophages [6], and synergizes with IL-1β and TNF-α in many cell backgrounds to increase the synthesis of pro-inflammatory effectors such as IL-6, IL-8 and matrix mellaproteinases [7,8].”
Minireview: The OPG/RANKL/RANK System
Khosla, S. (2001) · Endocrinology · doi:10.1210/endo.142.12.8536 · Cited by 1,515 · cited 1×
“RANKL is inhibited by a soluble decoy receptor OPG (osteoprotegerin), which binds to RANK and prevents osteoclastogenesis [31,32].”
BackgroundIncreased Osteoclast Development After Estrogen Loss: Mediation by Interleukin-6
Jilka, R. L., Hangoc, G., Girasole, G., Passeri, G., Williams, D. C., Abrams, J. S., Boyce, B., Broxmeyer, H., & Manolagas, S. C. (1992) · Science · doi:10.1126/science.1621100 · Cited by 1,442
Manolagas, S. C. (2000) · Endocrine Reviews · doi:10.1210/er.21.2.115 · Cited by 1,318
The Osteoblast: A Sophisticated Fibroblast under Central Surveillance
Ducy, P., Schinke, T., & Karsenty, G. (2000) · Science · doi:10.1126/science.289.5484.1501 · Cited by 1,120 · cited 1×
“Leptin has been shown to cause bone loss through a central pathway in the hypothalamus [27].”
Cited by
The IL-17 Family of Cytokines in Health and Disease
McGeachy, M. J., Cua, D. J., & Gaffen, S. L. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.021 · Cited by 1,443
“Mice deficient in IL-17 and fed regular chow gain increased fat mass with age, corresponding to a role for IL-17 in regulating glucose homeostasis and inhibiting adipogenesis (Ahmed and Gaffen, 2013; Goswami et al., 2009; Zuniga et al., 2010).”
BackgroundSelf-citationOsteoimmunology: The conceptual framework unifying the immune and skeletal systems
Okamoto, K., Nakashima, T., Shinohara, M., Negishi-Koga, T., Komatsu, N., Terashima, A., Sawa, S., Nitta, T., & Takayanagi, H. (2017) · Physiological Reviews · doi:10.1152/physrev.00036.2016 · Cited by 534
“However, inconsistent results have been reported on the role of IL-17 receptor IL-17RA in the pathogenesis of estrogen deficiency-induced osteoporosis; IL-17RA-deficient mice reportedly have a lower bone mineral density than wildtype mice after Ovx (141).”
ResultIL-17 regulates adipogenesis, glucose homeostasis, and obesity
Zúñiga, L. A., Shen, W.-J., Joyce-Shaikh, B., Pyatnova, E. A., Richards, A. G., Thom, C., Andrade, S. M., Cua, D. J., Kraemer, F. B., & Butcher, E. C. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001269 · Cited by 394
Vitamin D and Bone Health; Potential Mechanisms
Laird, E., Ward, M., McSorley, E., Strain, J. J., & Wallace, J. (2010) · Nutrients · doi:10.3390/nu2070693 · Cited by 358
Tyagi, A. M., Srivastava, K., Mansoori, M. N., Trivedi, R., Chattopadhyay, N., & Singh, D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044552 · Cited by 326
“While the studies by Goswami et al, 2009 [26] have shown that Ovx IL-17 receptor knockout mice were more susceptible to bone loss than controls thus suggesting a bone protective role for IL-17 receptor signalling, contrasting observations by our group [27] and DeSelm et al [28] suggested that IL-17…”
Result
Metadata
- Authors
- Goswami, J., Hernández‐Santos, N., Zuniga, L. A., & Gaffen, S. L.
- Affiliations
- University of Pittsburgh (US)
- Stanford University (US)
- Corresponding author
- Gaffen, Sarah L.
- Venue
- European Journal of Immunology
- Publisher
- Wiley
- Published
- 2009-10
- Volume
- 39
- Issue
- 10
- Pages
- 2831-2839
- ISSN
- 0014-2980 (ISSN-L)
- 1521-4141
- PMC
- PMC2811493
- OpenAlex
- W2122724238
- Cited by
- 87
- References
- 51
- Citations by year
- 2026: 4 · 2025: 4 · 2024: 2 · 2023: 7 · 2022: 3 · 2021: 7 · 2020: 3 · 2019: 4 · 2018: 7 · 2017: 3 · 2016: 7 · 2015: 3 · 2014: 3 · 2013: 9 · 2012: 11
- FWCI
- 2.82
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- European Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Amgen
- State University of New York
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases (F31-AI073198-02, F31AI073198)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (AR054389, R01AR054389)
- National Institute of Dental and Craniofacial Research (DE019424, R01DE019424)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
- Keywords
- IL-17A, IL-17 receptor, ovariectomy-induced bone loss, postmenopausal osteoporosis, estrogen deficiency, leptin, adipogenesis, 3T3-L1 preadipocytes, Th17 cells, bone turnover, IL-17F
- MeSH terms
- Animals, Estrogens, Female, Mice, Inbred C57BL, Models, Biological, Osteoporosis, Ovariectomy, Spine, Tumor Necrosis Factor-alpha, Signal Transduction, Weight Gain, Bone Density, Down-Regulation, Cytokines, Adipocytes, Mice, Knockout, Interleukin-17, Leptin, 3T3-L1 Cells, Adipogenesis, Mice, Receptors, Interleukin-17
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A bone-protective role for IL-17 receptor signaling in ovariectomy-induced bone loss. https://app.cochat.ai/papers/10.1002/eji.200939670
- The paper
- Goswami, J., Hernández‐Santos, N., Zuniga, L. A., & Gaffen, S. L. (2009). A bone-protective role for IL-17 receptor signaling in ovariectomy-induced bone loss. European Journal of Immunology. https://doi.org/10.1002/eji.200939670
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.